Columbia Sportswear Company COLM
Composite 56/100; the shares have moved about 33% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 22/100 — a strong mark against it.
Balance-sheet strength ranks 84/100 — a strong point in its favour. Valuation ranks 70/100 — a moderate point in its favour. Income ranks 61/100 — a slight point in its favour.
Growth ranks 22/100 — a strong mark against it. Momentum ranks 33/100 — a moderate mark against it.
What the company does Columbia Sportswear designs, markets, and distributes outdoor, active, and lifestyle apparel, footwear, and equipment under brands including Columbia, Mountain Hardwear, PRANA, and SOREL. Its products target hiking, trail running, snow, fishing, hunting, and general outdoor activities, sold via wholesale and direct-to-consumer channels globally.
Key financials Revenue growth is flat at 0.1%, while EPS declined -13.3%. Margins: gross 50.5%, operating 5.4%, net 5.0%. ROE 10.3%, ROA 5.5%, ROCE 10.9%. Debt/equity 0.30, current ratio 3.07, net debt/EBITDA -0.22. Dividend yield 1.9%, payout 38.3%.
Stock health Sideravia scores: overall 54.6 (weak quality, fairly valued), quality 43.3, growth 13.2, strength 89.5, valuation 61.1, momentum 53.7, income 72.6. Piotroski F-Score 6/9, Altman Z 4.97. RSI(14) 48.00, -9.08% below 52w high.
Price vs fair value The stock trades at a PREMIUM of 3.70% to our fair-value estimate of 60.47 and at a discount of 12.81% to the analyst 12-month target of 70.83. - Q2 CY2026 results beat revenue estimates despite a reported loss (Zacks, 2026-07-30) - Earnings call highlights emphasize operational progress (MarketBeat, 2026-07-30) - Simply Wall St argues 11% undervaluation based on raised 2026 guidance (Simply Wall St, 2026-07-31) - Some outlets remain cautious, listing COLM among “3 unpopular stocks we steer clear of” (StockStory, 2026-07-31)
Looking forward Forward P/E 15.58 and PEG 0.56 suggest valuation support, while weak growth (13.2 percentile) and low ROE temper enthusiasm. Analysts’ 70.83 target implies ~19% upside from the current price.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.